{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:36:44Z","timestamp":1791851804898,"version":"4.3.4"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Patients with metabolic syndrome (MS) tend to suffer from comorbidities, and are often simultaneously affected by obesity, dysglycemia, hypertension, and dyslipidemia. This syndrome can be reversed if it is timely diagnosed and treated with a combination of risk factors-reducing lifestyle changes and a tailored pharmacological plan. Interval hypoxic-hyperoxic training (IHHT) has been shown as an effective program in reducing cardiovascular risk factors in patients with MS even in the absence of exercise. However, the influence of IHHT on the lipid profile and inflammation in this clinical population remains relatively unknown.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A prospective, single-center, randomized controlled trial was conducted on 65 (33 men) patients with MS aged 29\u201374 years, who were randomly allocated to the IHHT or control (sham) experimental groups. The IHHT group completed a 3-week, 5 days\/week intermittent exposure to hypoxia and hyperoxia. The control (sham) group followed the same protocol but was breathing room air instead. The primary endpoints were the lipid profile (concentrations of total cholesterol [TC], low-density lipoprotein [LDL], high-density lipoprotein [HDL], and triglycerides [TG]) and the inflammatory factors such as high-sensitivity C-reactive protein (hs-CRP), galectin-3, heat shock proteins (Hsp70). The secondary endpoints were alanine aminotransferase (ALT), aspartate aminotransferase (AST), N-terminal pro-hormone of brain natriuretic peptide level (NTproBNP), transforming growth factor beta-1 (TGF-beta1), heart-type fatty acid-binding protein (H-FABP), and nitric oxide synthase 2 (NOS2).<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> There were no differences between the two groups but the different baseline values have affected these results. The IHHT group demonstrated pre-post decrease in total cholesterol (<jats:italic>p<\/jats:italic> = 0.001), LDL (<jats:italic>p<\/jats:italic> = 0.001), and TG levels (<jats:italic>p<\/jats:italic> = 0.001). We have also found a decrease in the CRP-hs (<jats:italic>p<\/jats:italic> = 0.015) and Hsp70 (<jats:italic>p<\/jats:italic> = 0.006) in IHHT-group after intervention, and a significant decrease in pre-post (delta) differences of NTproBNP (<jats:italic>p<\/jats:italic> &amp;lt; 0.0001) in the IHHT group compared to the control group. In addition, the patients of the IHHT group showed a statistically significant decrease in pre-post differences of ALT and AST levels in comparison with the control group (<jats:italic>p<\/jats:italic> = 0.001). No significant IHHT complications or serious adverse events were observed.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> The IHHT appears to improve lipid profile and anti-inflammatory status. It is a safe, well-tolerated procedure, and could be recommended as an auxiliary treatment in patients suffering from MS, however, the experiment results were limited by the baseline group differences.<\/jats:p><jats:p><jats:bold>Clinical Trial Registration:<\/jats:bold><jats:ext-link>ClinicalTrials.gov<\/jats:ext-link>, identifier [NCT04791397]. Evaluation of the effect of IHHT on vascular stiffness and elasticity of the liver tissue in patients with MS.<\/jats:p>","DOI":"10.3389\/fcvm.2021.700826","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T11:17:40Z","timestamp":1630667860000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["The Effects of Intermittent Hypoxic\u2013Hyperoxic Exposures on Lipid Profile and Inflammation in Patients With Metabolic Syndrome"],"prefix":"10.3389","volume":"8","author":[{"given":"A. Bestavashvili","family":"Afina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Glazachev","family":"Oleg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Bestavashvili","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhif","family":"Ines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvorov","family":"Alexander Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Vorontsov","family":"Nikita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Tuter","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Gognieva","family":"Daria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Pavlov","family":"Chavdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Glushenkov","family":"Dmitriy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Sirkina","family":"Elena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Kaloshina","family":"Irina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kopylov","family":"Philippe Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,27]]},"reference":[{"key":"B1","first-page":"318","volume-title":"Metabolic Syndrome","author":"Chazova","year":"2008"},{"key":"B2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-1-84628-911-8","volume-title":"The Metabolic Syndrome in Clinical Practice","author":"Mittal","year":"2008"},{"key":"B3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/1753944717711379","article-title":"Metabolic syndrome: pathophysiology, management, and modulation by natural compounds","volume":"11","author":"Rochlani","year":"2017","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/2047487319886404","article-title":"The metabolic syndrome \u2013 what is it and how should it be managed?","volume":"26","author":"Nilsson","year":"2019","journal-title":"Eur J Prevent Cardiol"},{"key":"B5","first-page":"51","article-title":"Interval hipo-hyperoxyc training in treatment of metabolic syndrome","volume":"7","author":"Glazachev","year":"2010","journal-title":"Klin Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11325-017-1459-8","article-title":"Intermittent hypoxia revisited: a promising non-pharmaceutical strategy to reduce cardiometabolic risk factors?","volume":"22","author":"Costalat","year":"2018","journal-title":"Sleep Breath."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1177\/1535370217723578","article-title":"Intermittent hypoxia training in prediabetes patients: beneficial effects on glucose homeostasis, hypoxia tolerance and gene expression","volume":"242","author":"Serebrovska","year":"2017","journal-title":"Exp Biol Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1089\/ham.2018.0014","article-title":"Intermittent hypoxia-hyperoxia conditioning improves cardiorespiratory fitness in older comorbid cardiac outpatients without hematological changes: a randomized controlled trial","volume":"19","author":"Dudnik","year":"2018","journal-title":"High Alt Med Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.2337\/dc12-2113","article-title":"Effects of a single bout of interval hypoxia on cardiorespiratory control and blood glucose in patients with type 2 diabetes","volume":"36","author":"Duennwald","year":"2013","journal-title":"Diabetes Care."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fped.2015.00058","article-title":"Hypoxic conditioning as a new therapeutic modality","volume":"3","author":"Verges","year":"2015","journal-title":"Front Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mehy.2017.01.010","article-title":"Intermittent hypoxia as a means to improve aerobic capacity in type 2 diabetes","volume":"100","author":"Leone","year":"2017","journal-title":"Med Hypotheses."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e13949","DOI":"10.14814\/phy2.13949","article-title":"Normobaric hypoxic conditioning in men with metabolic syndrome","volume":"6","author":"Klug","year":"2018","journal-title":"Physiol Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.3390\/ijms20215405","article-title":"Intermittent hypoxia-hyperoxia training improves cognitive function and decreases circulating biomarkers of Alzheimer's disease in patients with mild cognitive impairment","volume":"20","author":"Serebrovska","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B14","first-page":"251","article-title":"V, Sazontova TG, Tkatchouk EN, Meerson FZ. Adaptation to continuous and intermittent hypoxia: role of the active oxygen- dependent system","volume":"1","author":"Arkhipenko","year":"1997","journal-title":"Adapt Biol Med."},{"key":"B15","first-page":"793","article-title":"Adaptation to hypoxia and hyperoxia increases physical endurance: the role of reactive oxygen species and redox signaling (experimentally-applied research)","volume":"98","author":"Sazontova","year":"2012","journal-title":"I M Sechenov Ros Fiziol Zhurn."},{"key":"B16","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3389\/fphys.2019.00430","article-title":"Body composition and body weight changes at different altitude levels: a systematic review and meta-analysis","volume":"10","author":"Dunnwald","year":"2019","journal-title":"Front Physiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fspor.2020.00026","article-title":"An updated panorama of \u201cliving low-training high\u201d altitude\/hypoxic methods","volume":"2","author":"Girard","year":"2020","journal-title":"Front Sports Act Living."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1007\/s00421-020-04410-9","article-title":"Hypoxic training improves blood pressure, nitric oxide and hypoxia-inducible factor-1 alpha in hypertensive patients","volume":"120","author":"Muangritdech","year":"2020","journal-title":"Eur J Appl Physiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"R251","DOI":"10.1152\/ajpregu.00160.2017","article-title":"Normobaric hypoxic conditioning to maximize weight loss ameliorate cardio-metabolic health in obese populations: a systematic review","volume":"313","author":"Hobbins","year":"2017","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B20","article-title":"A device for performing complex interval normobaric hypoxic-hyperoxic training in a person","author":"Kostin","year":"2009","journal-title":"The patent of the Russian Federation for the invention No. 2365384 from August."},{"key":"B21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s13105-011-0115-1","article-title":"Usefulness of combining intermittent hypoxia and physical exercise in the treatment of obesity","volume":"68","author":"Urdampilleta","year":"2012","journal-title":"J Physiol Biochem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e13192","DOI":"10.1111\/obr.13192","article-title":"Hypoxia, energy balance, and obesity: an update","volume":"22","author":"Kayser","year":"2021","journal-title":"Obes Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fphys.2017.00073","article-title":"Walking in hypoxia: an efficient treatment to lessen mechanical constraints and improve health in obese individuals?","volume":"8","author":"Girard","year":"2017","journal-title":"Front Physiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1089\/ham.2018.0059","article-title":"Effects of high-intensity interval training under Normobaric hypoxia on cardiometabolic risk markers in overweight\/obese women","volume":"19","author":"Camacho-Cardenosa","year":"2018","journal-title":"High Alt Med Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000431157","article-title":"Normobaric Intermittent Hypoxia over 8 months does not reduce body weight and metabolic risk factors - a randomized, single blind, placebo-controlled study in normobaric hypoxia and Normobaric sham hypoxia","volume":"8","author":"Gatterer","year":"2015","journal-title":"Obes Facts."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-7075-9-103","article-title":"Post-metabolic response to passive normobaric hypoxic exposure in sedendary overweight males: a pilot study","volume":"9","author":"Workman","year":"2012","journal-title":"Nutr Metab."},{"key":"B27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/ham.2017.0050","article-title":"The use of simulated altitude techniques for beneficial cardiovascular health outcomes in nonathletic, sedentary, and clinical populations: a literature review","volume":"18","author":"Lizamore","year":"2017","journal-title":"High Alt Med Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fphys.2016.00202","article-title":"The effect of normobaric hypoxic confinement on metabolism","volume":"7","author":"Mekjavic","year":"2017","journal-title":"Front Physiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.15829\/1560-4071-2015-9-96-102","article-title":"Galectin-3 \u2014 biomarker of fibrosis in patients with metabolic syndrome","volume":"9","author":"Drapkina","year":"2015","journal-title":"Russ J Cardiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/oby.2009.8","article-title":"Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology","volume":"6","author":"Ren","year":"2009","journal-title":"Obes Res J"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X17666210514005235","article-title":"Safety and efficacy of intermittent hypoxia conditioning as a new rehabilitation\/ secondary prevention strategy for patients with cardiovascular diseases: a systematic review and meta-analysis","author":"Glazachev","year":"2021","journal-title":"Curr Cardiol Rev"},{"key":"B32","first-page":"44","article-title":"Influence of adaptation to different oxygen levels on physical endurance, free radical oxidation and urgent response proteins. Proceedings of the 5th Ros. conf. \u201cHypoxia: mechanisms, adaptation, correction\u201d","volume":"3","author":"Archipenko Yu","year":"2008","journal-title":"Pathogenesis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ijcard.2003.07.021","article-title":"Intermittent hypoxia increases exercise tolerance in elderly men with and without coronary artery disease","volume":"96","author":"Burtscher","year":"2004","journal-title":"Int J Cardiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3390\/biom10060958","article-title":"The hyperoxic-hypoxic paradox","volume":"10","author":"Hadanny","year":"2020","journal-title":"Biomolecules."},{"key":"B35","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/B978-0-12-815854-8.00047-1","article-title":"Hypoxic\u2013hyperoxic conditioning and dementia","volume":"47","author":"Mallet","year":"2020","journal-title":"Diagn Manage Dement."},{"key":"B36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.physbeh.2019.04.027","article-title":"Additive stress of normobaric hypoxic conditioning to improve body mass loss and cardiometabolic markers in individuals with overweight or obesity: a systematic review and meta-analysis","volume":"207","author":"Ramos-Campo","year":"2019","journal-title":"Physiol Behav."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.700826\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T14:00:29Z","timestamp":1631887229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.700826\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,27]]},"references-count":36,"alternative-id":["10.3389\/fcvm.2021.700826"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.700826","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,27]]},"article-number":"700826"}}